The global disposable syringes market size is expected to reach USD 22.81 billion by 2030, registering a CAGR of 6.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by factors, such as a rise in technological advancements and a high incidence of obesity. Moreover, the increasing adoption of safety syringes and prevalence of diabetes drive market growth. Leading manufacturers are focusing on technological innovations and developing advanced products to gain substantial market shares. Increasing prevalence of chronic disorders, such as diabetes, can be managed by self-injecting medication. Growing cases of chronic diseases and a rising number of vaccinations that make extensive use of syringes, such as single-use and disposable syringes, are boosting market growth.
According to the International Diabetes Federation (IDF) Diabetics Atlas, the diabetic population is anticipated to grow by 46.0% reaching 643 million (1 in 9 adults) by 2030, and likely to majorly rise in middle-income countries, as compared to the developed countries. North America dominated the market in 2022 with a share of over 40%. MEA has the highest prevalence of diabetes in countries like Kuwait, Saudi Arabia, and Bahrain; thus, the region is anticipated to register the fastest CAGR of 6.9% from 2023 to 2030. Moreover, the presence of untapped opportunities in the emerging economies of Saudi Arabia and Kuwait will support regional market growth.
Request a free sample copy or view report summary: Disposable Syringes Market Report
The conventional syringes segment accounted for the largest share of around 53% in 2022. The use of injection and auto-injectors comprises the use of needles. Conventional syringes are the most practiced and used syringes in homecare settings. For instance, B.D.’s conventional syringes and needles range, the conventional disposable syringes guarantee protection for the patient receiving it. Such factors are likely to drive segment growth
The safety syringes segment is estimated to register the fastest CAGR of 6.4% from 2023 to 2030. Safety syringes are required for most diagnostic and therapeutic approaches for chronic diseases since they are essential during medication administration and tests, resulting in rising product demand. In 2019, Japanese firm Morimoto Pharma launched a S.A.F.E. Syringe Kit vial comprising pre-attached needle syringes and a tube-shaped container into an innovative synergistic design. Such innovations are expected to ease product usage for healthcare workers
The hospital end-use segment accounted for the largest revenue share of over 50% in 2022 due to studies being meticulously designed to maximize the chances of detecting meaningful treatment. The demand for dispensing syringes in hospitals continues to rise. Prefilled and disposable syringes are becoming increasingly common in some European states due to the use of prefilled syringes in ICUs and operating theaters
Grand View Research has segmented the global disposable syringes market based on syringe type, end-use, and region:
Disposable Syringes Type Outlook (Revenue, USD Million, 2018 - 2030)
Conventional Syringes
Safety Syringes
Retractable Safety Syringes
Non-retractable Safety Syringes
Disposable Syringes End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Research & Manufacturing
Disposable Syringes Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Norway
Sweden
Denmark
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in Disposable Syringes Market
Medtronic
Nipro Corporation
Fresenius Kabi Ag
Baxter International
Braun Medical, Inc
Becton, Dickinson. and Company (Bd)
Flextronics International Vita Needle Company
Terumo Corporation
Novo Nordisk
Ultimed, Inc.
Henke-Sass, Wolf
Retractable Technologies, Inc.
"The quality of research they have done for us has been excellent..."